Invalid date chosen. Displaying data for the latest date instead.
Intrahepatic Cholestasis Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
ABT | F | Abbott Laboratories | 0.44 | |
MIRM | F | Mirum Pharmaceuticals, Inc. | -1.68 |
Related Industries: Biotechnology Medical Devices
Related ETFs - A few ETFs which own one or more of the above listed Intrahepatic Cholestasis stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IHI | D | iShares U.S. Medical Devices ETF | 16.17 | |
PJP | B | PowerShares Dynamic Pharmaceuticals | 5.18 | |
PCGG | F | Polen Capital Global Growth ETF | 4.58 | |
HART | B | IQ Healthy Hearts ETF | 4.3 | |
VIRS | A | Pacer BioThreat Strategy ETF | 4.16 |
Compare ETFs
Related Industries:
Biotechnology
Medical Devices
- Intrahepatic Cholestasis
Intrahepatic cholestasis is a condition in which the flow of bile from the liver is blocked or reduced. This can lead to a buildup of bile acids in the liver and other organs, causing symptoms such as itching, jaundice, and dark urine. It can be caused by a variety of conditions, including liver disease, certain medications, and pregnancy. Treatment depends on the underlying cause.
Recent Comments
- TraderMike on Market Recap for Tuesday, May 21, 2024
- CharmingMole371 on Market Recap for Tuesday, May 21, 2024
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
From the Blog
Featured Articles